| Autor: |
Cheng, H., Gomes-Trolin, C., Aquilonius, S.-M., Steinberg, A., Löfberg, C., Ekblom, J., Oreland, L. |
| Zdroj: |
Experimental Neurology; June 1997, Vol. 145 Issue: 2 p580-585, 6p |
| Abstrakt: |
In the present study, levels ofS-adenosylmethionine (SAM) andS-adenosylhomocysteine (SAH) in whole blood as well asl-methionineS-adenosyltransferase (MAT) activity in erythrocytes were assayed in a series of 20 patients with Parkinson's disease and 12 healthy control subjects. A significant difference was found with regard to SAM levels between patients and controls, with the detected levels being 383.1 ± 41.5 nMfor the parkinsonian patients and 680.6 ± 30.9 nMfor the controls. With regard to SAH, we found no difference between the groups. The catalytic activity of MAT was increased by 30% in patients compared to controls, with theVmaxfor methionine being 17.9 ± 3.7 and 13.9 ± 2.2 pmol/mg/h, respectively. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full Text from ScienceDirect